362

  1. FDA misses review deadline for genetic drug candidate.
  2. Supreme Court sides with HHS on hospital reimbursement.
  3. Tenet to continue M&A for ambulatory surgery centers
  4. C-suite compensation grew 20% in 2024
  5. FDA ruling ends era of compounded GLP-1 weight-loss drugs.
  6. Humana to shore up Medicare Advantage business
  7. Penn. legislation would legalize OTC ivermectin legality
  8. GOP senator calls for reversal of federal research cuts.
  9. FDA debates whether to approve seasonal COVID shots.
  10. RFK Jr.: Don’t flush unused medications.
Get the top digital health stories right in your inbox

You might also like

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Digital Health Wire team

You're all set!